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Objectives: To characterize by spoligotyping clinical isolates of Mycobacterium tuberculosis
(MTB) collected between July 2003 and October 2005 from all Syrian provinces (muhafazat).
Methods: All isolates (n = 96) were cultured and identified by biochemical characteristics.
DNA extracts of these samples were amplified by PCR and genotyped by spoligotyping.
Results: Twelve patterns were identified: 46.8% of the strains belonged to T 1 family; 20.8%
to LAM 9; 10.4% to CAS; 9.3% to Haarlem 3; 4.1% to Haarlem 1; 2.1% to Family 34; and 1% to
each of Family 36, EAI 5, LAM 1, LAM 8, T 3, and X 3 families. The noticeable absence of the
Beijing family was not consistent with the patterns reported in most neighboring countries.
Conclusion: Amore inclusive study of the Syrian population is necessary to more accurately
identify most of the prevailing families in the country.
 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction
Tuberculosis (TB) remains a major cause of morbidity and
mortality worldwide. The World Health Organization (WHO)
estimates that approximately one-third of the global commu-
nity is infected with Mycobacterium tuberculosis (MTB) [1]. In
2011, there were an estimated 8.7 million new cases of TB
(13% co-infected with HIV) and 1.4 million people died from
TB, including almost 1 million deaths among HIV-negative
individuals and 430,000 among people who were HIV-positive
[1]. Globally, there were an estimated 0.4 million HIV-associ-
ated TB deaths in 2011, with approximately equal numbers
among men and women. WHO, UNAIDS and the Stop TB
Partnership have set a target of halving TB mortality rates
among people who are HIV-positive by 2015 compared with-African Society for Myco
32.
ahmo).2004 (the year in which TB mortality among HIV-positive peo-
ple is estimated to have peaked) [2].
Recent studies have shown associations among MTB
strains, geographic regions, and human populations. These
indicate that specific strains of MTB co-evolved with human
subpopulations [3].
Molecular tools have enhanced the understanding of the
epidemiology of TB by providing new insight on the transmis-
sion, dynamics, source, and spread of MTB [4,5]. Molecular
typing methods used to determine clonal and phylogenetic
relationships of MTB strains provide useful data about epide-
miology of TB in a given population, in a given country,
among countries and throughout the world [6]. The
spoligotyping method has been widely accepted as a valuable
tool for epidemiological studies of TB. It has proven useful forbacteriology. Published by Elsevier Ltd. All rights reserved.
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and for a description of the global spread of TB [7–10].
Many genetic loci within the MTB complex (MTC) genomes
are polymorphic and may be used for molecular evolutionary
studies [11]. Among these, the Direct Repeat (DR) locus, which
consists of alternating identical DRs and variable spacers, can
be genotyped using the spoligotyping method [12]. This PCR-
based reverse-hybridization blotting technique is easy, ro-
bust, cheap, and produces highly diverse portable numerical
results [6]. It can be applied directly to clinical samples, thus
allowing fingerprinting of a large number of isolates to be per-
formed in a very short time [13].
International databases, such as the SpolDB3.0 have re-
vealed the clonal structure of MTB isolates in different geo-
graphical settings. SpolDB4.0 data base further defines
super-families specific to certain locations [14]. The abun-
dance of polymorphisms indicates that transposition and
homologous recombination are the major events contributing
to the diversity of MTB strains [15].
The SyrianArab Republic is considered an endemic country
for TB, with an intermediate burden of disease, an estimated
incidence for all cases in 2006 of 32 per 100,000 population
and a TB prevalence of 40 per 100,000 population [16].
In the mid-1990s, Syria decided to implement the DOTS
(the directly observed treatment, short course) strategy, thus
providing the basis to integrate TB treatment into the network
of primary health care (PHC) centers. TB control strategy en-
tails the use of short-course regimens of effective drug com-
binations, direct supervision of treatment for at least the
first 2 months, and evaluation of treatment for each patient
[17]. The program achieved a cure rate of 92% in Syria [18].
A previous study using double-repetitive element polymer-
ase chain reaction (DRE-PCR) method for the proximity of theFig. 1 – An autoradiographic fingerprint prrepetitive DNA elements IS6110 (a mobile genetic element),
PGRS, demonstrates that various genotypes tended to be
more common in specific regions than others [19]. The selec-
tive distribution of genotype groups, in addition to the ob-
served high level of variability, indicated some level of
geographic isolation, and hence separate evolution. It justifies
also the initial assignment of the genotypes to major groups
according to the observed general amplicon band pattern.
Genotyping MTB in Syria on the national level in parallel
with DOTS may prove to be informative and beneficial as
DOTS subjects will be closely assessed and monitored for
therapeutic response.
This investigation reports on the first nationwide study to
characterize clinical isolates of MTB from different regions of
Syria. This study could provide some insight into the dynam-
ics of the disease and the possible routes of TB transmission.Materials and methods
Sampling of patients
Following an agreement with the Syrian Ministry of Health,
samples from 96 patients previously treated for pulmonary
TB were obtained. These included cases of failure after first
treatment, relapse or reinfection. The samples, provided by
the Ministry’s central laboratory, were collected between July
2003 and October 2005 from all Syrian provinces (muhafazat).
They were shipped, accompanied by the related information,
to the medical biotech Laboratory of the National Commis-
sion for Biotechnology in the Syrian Arab Republic. The re-
search was approved by the responsible ethical committee
at the Ministry of Higher Education.ototype of some of the samples tested.
Table 1 – The spoligopatterns of the Syrian samples tested include: the binary formats, the octal formats, the most probable
families and the shared types to which they belong (A black square indicates the presence of a spacer, and a blank one its
absence).
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Processing of sputum specimens was based on liquefaction
and decontamination by 2% N-acetyl-L-cysteine-NaOH. Bacte-rial culture was performed on solid Lowenstein–Jensen
medium [20]. Sputum was digested and decontaminated with
N-acetyl-L-cysteine-sodium hydroxide for culture of
mycobacteria.
Table 2 – Prevalence of the different Mycobacterium tubercu-
losis complex family strains in the Syrian sample pool
(n = 96).
Family strains Nb. Percentage
T1 45 46.8
LAM 9 20 20.8
CAS 10 10.4
Haarlem 3 9 9.3
Haarlem 1 4 4.1
Family 34 2 2.1
Family 36 1 1.0
EAI 5 1 1.0
LAM 1 1 1.0
LAM 8 1 1.0
T 3 1 1.0
X 3 1 1.0
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Identity of strainswas based on the following biochemical char-
acteristics: production of Niacin, Nitrate reductase, catalase at
laboratory temperature, catalase at 68 C, hydrolysis of Tween
80 in 10 days, urease in 18 h, and arylsulfatase in 3 days [14].
DNA extraction
A loopful of each culture was suspended in ATL buffer
(0.2 mL). DNA samples were extracted in a laboratory free of
all mycobacterial products using QIAamp DNA blood Mini
Kit (Qiagene). The accompanied procedure was adhered to ex-
cept for the incubation period that was extended to 3 h. DNA
was eluted in 100 lL PCR water (Gibco).
PCR amplification
All DNA samples were positive for the IS6110 as determined
by PCR amplification followed by detection by agarose gel
electrophoresis using the method of Wilson et al. [21]. PCR
set-up was also performed in a remote area, separate from
all subsequent procedures. Measures to avoid cross and car-
ry-over PCR contaminations were observed; use of aerosol
barrier-fitted pipette tips and of molecular biology-grade
water and reagents, in addition to frequent decontamination
of surface work areas with diluted bleach and short-UV were
regularly performed between experiments.
Spoligotyping was performed for each sample in duplicates
and was initially repeated twice to assess the reproducibility
of the method. Duplicate positive and negative controls were
included in each run. DNAwas replacedwithwater in negative
control reactions andDNAofMTB strainsH37Rv andMycobac-
terium Bovis BCG P3 supplied in the kit were used in positive
control reactions. The procedure was performed using a re-
verse dot-blot spoligotyping kit with chemiluminescent
detection (Isogen Bioscience B.V., BT Maarssen, the
Netherlands) as follows: 5 lL of mycobacterial DNAwas added
toaPCRamplification reaction inwhich the forwardDR-primer
was biotinylated. Amplificationwas performed for 25 cycles as
recommended by the manufacturer.Spoligo-membranes were regenerated 3–5 times by wash-
ing in 1% SDS at 80 C for 30 min to 1 h, then in 20 mM EDTA,
pH 8.0 for 15 min at room temperature. The membrane was
then incubated in ECL detection liquid and re-exposed to a
light-sensitive film for a few minutes. Washes were repeated
when necessary to eliminate all residual signals. The mem-
brane was then stored at 4 C until reuse. It is worth noting
that the binary to octal translation was done using spotclust
[22].
Results
A total of 96 clinical samples have been tested by spoligotyp-
ing. Fig. 1 shows the autoradiographic fingerprinting of some
of the samples tested. In the 43 spacers, black dots reveal a
hybridization pattern. Within the same run, each specimen
is tested in duplicates and is repeatedly tested in other runs
for reproducibility. Each run includes a positive control
(H37Rv), BCG, and a blank specimen. These spoligopatterns
are then translated into digital binary formats where ‘‘1’’ indi-
cates hybridization and ‘‘0’’ its absence. The digital formats
are then expressed as octal formats and the results inter-
preted as the most probable family to which a particular spec-
imen belongs. Table 1 is a summary of the spoligopatterns of
the 96 specimens tested, the most probable families to which
they belong and the shared type (ST) designation of each. Ta-
ble 2 indicates the prevalence of the different MTB complex
family strains in the tested samples. Table 3 denotes a de-
tailed analysis of the different MTB complex family clades
with the individual shared type (ST) designation, the number
of isolates and the corresponding lack of spacers for each.
Discussion
In the present study, among the 96 isolates tested, 12 different
spoligotype patternswere identified, indicating the significant
heterogeneity of the population studied. However, upon phy-
logenetic analysis, the vast majority of the genotypes were
allocated to only two major clades, namely, the T and LAM 9
clades, which covered 45 (46.8%) and 20 (20.8%) of the MTB
strains analyzed, respectively.
According to the SolDB4 database, the ‘‘ill-defined’’ T family
is characterizedby the absenceof spacers 33–36. It clusters var-
ious strains whose evolution remains unresolved. This family
is widely present in all continents and corresponds to about
30% of all entries in the international database [6]. Most of
the T1 family in this study (31.1%) belonged to ST53, 12
(26.6%) to 284; 3 (6.66%) to 131; 2 (4.44%) to 1,475; 2 (4.44%) to
52; and 1 (2.22%) to each of 353, 926, 51 and 771 shared types.
Eight (17.77%) of theT1 strainswith the followingoctal descrip-
tions [037017777760771 (n = 3), 777777 777740171 (n = 1),
437737777760771 (n = 1), 037637777 760731 (n = 2),
777777774760777 (n = 1)] could not be classified under any of
the shared types in the SpolDB4 database. One unclassified
specimen (1%)with an octal format 777003777760771 belonged
to the T3 family (absence of spacers 13–16 and 33–36).
The second predominant family in these results, the LAM 9
family constituted 20.8% (n = 20) of the specimen; 13 (65%) be-
longed to ST 41; 2 (10%) to ST 367; and 1 (5%) to ST 120. Four
Table 3 – Summary of the different clades identified, their shared type designations, the number of isolates and
the absence of spacers for the specimen tested.
Clade Shared types Number of isolates Absent spacers/No.
T 1 53 14 33–36/14
284 12 1–4, 12–13, 33–36/12
131 3 13–14, 33–36/3
1475 2 10, 14, 33–36/2
52 2 33–36, 40/1
13, 33–36, 40/1
353 1 26–27, 33–36/1
926 1 7, 33–36/1
51 1 33–36, 40–43/1
771 1 22–23, 33–36/1
Unclassified 8 1–4, 10–14, 33–36/3
1–4, 12–13, 33–36, 40/1
2–4, 13, 33–36/1
26–27, 33–36/1
1–6, 33–36/1
32–38/1
T 3 Unclassified 1 10–16, 33–36/1
LAM 9 41 13 20–24, 26–27, 33–36/13
367 2 13, 20–24, 26–27, 33–36/2
120 1 20, 33–36/1
Unclassified 4 21–28, 33–36/2
4, 20–24, 26–27, 33–36/1
4–7, 23–24, 37–38/1
LAM 8 Unclassified 1 9–10, 22–30, 33–36/1
LAM 1 Unclassified 1 2–3, 12, 19–24, 33–36/1
Haarlem 1 602 3 25–36/3
Unclassified 1 24–36/1
Haarlem 3 1884 3 4–7, 20–35/1
17–18, 28–38/1
32–38/1
1276 1 10–14, 29–31, 33–36/1
777 1 29–31, 33–36/1
Unclassified 4 1–4, 12–13, 31, 33–36/1
1–4, 10–13, 33–36/1
31, 33–36/1
28–38/1
CAS 25 2 4–7, 23–34, 37–38/1
26 2 4–7, 23–34/2
600 1 4–7, 20–34, 37–38/1
22 1 4–7, 20–35/1
1093 1 4–7, 21–34,36–39/1
599 1 4–7, 20–36/1
Unclassified 2 4–7, 10, 14, 21–34, 36–38/1
4–8, 10–12, 14–15, 17–18,
23–34, 37–39 /1
EAI 5 8 1 2–13, 29–32, 34/1
Family 36 4 1 1–24, 33–36/1
Family 34 46 1 25–43/1
Unclassified 1 4–7, 18, 25–43/1
X 3 Unclassified 1 4–11, 33–36/1
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[777777600360771 (n = 2), 773736000760771 (n = 1) 73777
7404760777 (n = 1)] could not be classified in the database.
One specimen (1%) with an octal format 477677 007760771
belonging to LAM 1 family (absence of spacers 3, 21–24, 33–36)
and another with an octal format 7763777 00060771 belonging
to the LAM 8 family (absence of spacers 22–24, 27–30, 33–36)
could not be classified in the database. This Latin American
andMediterranean (LAM) super family is defined by the simul-
taneous absence of spacers 21–24, and 33–36 [14]. In general,
the LAM family is found to be the highest in Venezuela (65%),in the Mediterranean basin (e.g., 34% in Algeria, 55% in Moroc-
co, 30% in Spain), and in the Caribbean region (30% in Cuba and
Haiti, 17.4% in French Guiana, 15% in FrenchCaribbean islands
[23]. Syria‘s geographical location in the Mediterranean basin
and the great tendency of the Syrians, since ancient times, to
immigrate to Venezuela, Central America and to some other
African countries, with intermittent visits to their mother
country could explain these findings.
TheCentral Asian (CAS) lineage covered10.4% (n = 10) of the
samples tested; 2 (20%) belonged to ST25; 2 (20%) to ST26; and1
(10%) to each of 600, 22, 1093 and 599 STs. CAS members with
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703357600002171 (n = 1)] couldnot be classified in thedatabase.
This family is characterized by the absence of spacers 4–7, and
23–34. Strains of this family have been reported in different
countries of the Middle East (Iran, Pakistan, India and Afghan-
istan) [24,25] and toa lesserextent inother regions (Africa 5.3%,
Central America 0.1%, Europe 3.3%, Far-East Asia 0.4%, North
America 3.3%, Oceania 4.8%). Nowadays, the CAS 1-Delhi fam-
ily is essentially localized in the Middle-East and Central Asia,
more specifically in South-Asia (21.2%) andpreferentially in In-
dia (75%) [25,26]. Interestingly enough, recently this family
composed 14.2% of the Iranian and Afghan MDR (multidrug
resistant) TB patient communities [25].
In the Haarlem (H) lineage, 9.3% of the samples belonged
to Haarlem 3 and 4.1% to Haarlem 1 families. Of the Haarlem
3 family, 3 specimens (33.3%) belonged to ST 1884, and 1
(11.1%) to each of ST 1276, 50 and 777. Three strains (33.3%)
with the following octal descriptions [037637777720771
(n = 1), 037037777760771 (n = 1) and 777777777000171 (n = 1)]
could not be classified. Concerning the Haarlem 1 family, 3
(75%) belonged to ST 602 and 1 (25%) with the octal format
777777760000771 could not be classified. Haarlem is charac-
terized by the absence of spacers 26–31 and 33–36. In Europe,
this lineage represents about 25% of the isolates [7]. Outside
Europe, the Haarlem strains were mainly found in Central
America and the Caribbean (about 25%), suggesting a link of
Haarlem to the post-Columbus European colonization [24].
Today its widespread distribution in different geographical re-
gions of the world such as Asia, Europe and Africa has been
documented [27]. However, these organisms of European des-
cent were rarely found in India [28]. This family accounts for
more than half (57.1%) of all clustered strains among Iranian
MDR-TB patients [25], thus, necessitating from an epidemio-
logical point, extensive surveillance of MDR strains because
they might cause serious outbreaks. It is characterized by
the absence of spacers 29–31, and 33–36 (prototypes ST 127
and/or ST 777). The ST 777 pattern isolated in this specimen
is mainly found in Saudi Arabia, Kazakhstan, Russia and
Georgia [29]. Thus, the presence of Haarlem is related to the
historical contacts that existed between Syria and most of
the European communities, in addition to Arab countries
such as Saudi Arabia where many Syrians went seeking work.
In this study, 2 (2.1%) specimens belonged to family 34 (ab-
sence of spacers 25–43), one (50%) with an ST 46 designation
and another one (50%) with an octal format 70377677000 0000
was unclassified; 1% (n = 1) of the samples belonged to family
36 (ST 4), characterized by the absence of spacers 1–24 and
33–36. Until the present, this family is solely of USA origin [22].
Nearly 1% (n = 1) of the sampleswith a database signature ST
8 belonged to the East-African-Indian (EAI 5) lineage. The EAI
super family is characterized by the presence of spacer 33 and
the absence of spacers 29–32 and 34. It is highly prevalent in
South-East-Asia, particularly in the Philippines (73%) [30],
Myanmar and Malaysia (53%) [31], and in 17% of MTB isolates
from patients with pulmonary tuberculosis in Mumbai, India
[29]. In addition, it is one of the most frequent strains (12.9%)
in Iranian and Afghan MDR-TB patient communities [25].
Nearly 1% of the samples belonging to the X3 family and
with an octal format 700177777760771 could not be classified.
The X super family is defined by the simultaneous absence ofspacers 4–12, 18 and 33–36. It is subdivided into at least three
distinct families: X1 to X3 [26]. Nowadays, this group of
strains is currently correlated with African-Americans [30].
Noticeably enough, in the samples tested, none belonged to
the Beijing family (characterized by the absence of spacers 1–
34), which is quite prevalent in the countries of theMiddle East
and Far East. Actually, they represent around 50%of the strains
in Far-East-Asia, 16.5% in the Middle East and Central Asia,
17.2% in Oceania [5], 10% in India [28], and 13% of isolates glob-
ally [5]. In addition, it accounts for 15.5% of the isolates in the
MDR – TB in Iranian and Afghan patients [25].A previous study
run in Syria [32] indicated the absence of any Beijing strain in
the samples tested. Such absence should be further confirmed
through larger sampling pools given the proven presence of
these strains in neighboring countries (Turkey, Palestine, Saudi
Arabia) [33]. On the other hand, it is possible that the Syrian
population is less prone to infection by the Beijing family of
strains [34]. This has been earlier hypothesized for other cases
of limited spread of the Beijing genotype [35].
Conclusion
The results of this study fit fairly well with the molecular epi-
demiology of MTB genotypes described in the international
database. Several unclassified strains were detected, 8 belong-
ing to the T 1 family, 4 to each of LAM 9 and Haarlem 3, 2 to
CAS, and 1 to each of T 3, LAM 8, LAM 1, Haarlem 1, EAI 5,
Family 34 and X 3 families. This indicates a great variability
and polymorphism in the strains studied. However, the ab-
sence of Beijing is not consistent with the patterns reported
in neighboring countries, despite the fact that Syria is open
to workers from the Far and Middle East (Philippines, Bangla-
desh, Nepal, Srilanka, India, Pakistan, Iran, Russia, Iraq, etc.),
and from Africa (Egypt, Sudan, Ethiopia, etc.). A more inclu-
sive study of the Syrian population is necessary to more accu-
rately identify most of the prevailing families in this country
and to further extrapolate the benefits for prevention and
possibly treatment of tuberculosis.
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